Party with a Purpose Honors Former Mayor and Prostate Cancer Advocate Michael Nutter
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
Three patients share their experiences about having Lynch syndrome.
Researchers are exploring new options for kidney cancer treatments.